Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2013-06-30
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Autism Spectrum Disorders (ASD) Characterization Study
NCT00801554
Phenotypic and Genetic Factors in Autism Spectrum Disorders
NCT00910559
Genetic Contributions to Autism Spectrum Disorders
NCT01160783
Improving the Part C Early Intervention Service Delivery System for Children with ASD
NCT05114538
REward SYSTem in Autism Spectrum Disorder and Addictive Disorder
NCT05391113
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aim 2: to complete a diagnostic assessment, to confirm the diagnosis of autism spectrum disorder or other developmental disability (e.g., developmental language delay) in our patient population and rule out a diagnosis of autism spectrum disorder and other comorbid conditions in our control group
Aim 3: to maintain subject information in a database, from which we can recruit for our studies
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy individuals
No intervention
Healthy participants ages 14-32 for a neuroimaging study.
No interventions assigned to this group
Individuals with Autism Spectrum Disorder
No intervention
ASD participants ages 14-32 for a neuroimaging study.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adolescents and adults with autism spectrum disorder (ages 14-32)
Exclusion Criteria
* Known genetic disorders related to autism (e.g. Fragile X)
* Recent diagnosis of psychosis (within 6 months)
* Some other psychiatric diagnoses may be excluded following screening (e.g. Tourette's syndrome).
* Metal implants / permanent retainers / hair dyes with metallic components
14 Years
32 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
National Institutes of Health (NIH)
NIH
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tal Kenet
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tal Kenet, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Martinos Center of Biomedical Imaging
Charlestown, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007-P-000062
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.